www.fdanews.com/articles/159630-tevaactives-ms-pill-shows-promise-in-brain-damage
Teva/Active’s MS Pill Shows Promise in Brain Damage
October 3, 2013
A Phase III trial testing Teva and Active Biotech’s laquinimod for multiple sclerosis (MS) has shown results in treating patients with brain damage due to MS.
Pharma Times
Pharma Times